A detailed history of Menora Mivtachim Holdings Ltd. transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Menora Mivtachim Holdings Ltd. holds 2,303,031 shares of URGN stock, worth $28.2 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
2,303,031
Previous 2,303,031 -0.0%
Holding current value
$28.2 Million
Previous $34.5 Million 11.87%
% of portfolio
0.27%
Previous 0.26%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$8.84 - $22.64 $2 Million - $5.13 Million
-226,789 Reduced 8.96%
2,303,031 $32.3 Million
Q2 2023

Jul 31, 2023

SELL
$8.75 - $14.29 $3.41 Million - $5.56 Million
-389,183 Reduced 13.33%
2,529,820 $26.2 Million
Q3 2022

Nov 14, 2022

SELL
$7.21 - $9.41 $219,804 - $286,873
-30,486 Reduced 1.03%
2,919,003 $24.3 Million
Q2 2022

Aug 08, 2022

SELL
$5.12 - $8.74 $15,360 - $26,220
-3,000 Reduced 0.1%
2,949,489 $24.2 Million
Q4 2021

Feb 10, 2022

SELL
$9.03 - $19.13 $19,956 - $42,277
-2,210 Reduced 0.07%
2,952,489 $28.1 Million
Q1 2019

May 14, 2019

BUY
$35.47 - $54.55 $16.1 Million - $24.8 Million
454,829 Added 18.19%
2,954,699 $109 Million
Q2 2018

Aug 01, 2018

BUY
$48.35 - $65.33 $22 Million - $29.7 Million
454,241 Added 22.21%
2,499,870 $124 Million
Q1 2018

May 14, 2018

BUY
$38.64 - $57.54 $20.7 Million - $30.8 Million
535,622 Added 35.47%
2,045,629 $102 Million
Q4 2017

Feb 13, 2018

BUY
$27.28 - $43.26 $25.7 Million - $40.7 Million
940,418 Added 165.1%
1,510,007 $56.2 Million
Q3 2017

Oct 30, 2017

BUY
$17.15 - $32.72 $9.77 Million - $18.6 Million
569,589
569,589 $18 Million

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $278M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Menora Mivtachim Holdings Ltd. Portfolio

Follow Menora Mivtachim Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menora Mivtachim Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Menora Mivtachim Holdings Ltd. with notifications on news.